Metronidazole/Prednisolone/Nystatin/Neomycin

甲硝唑/泼尼松龙/制霉菌素/新霉素

Report date: 2026/03/04 20:01:44

Base Information

Drug NameMetronidazole/Prednisolone/Nystatin/Neomycin
Drug Alias Name甲硝唑+泼尼松龙+制霉菌素+新霉素Metronidazole/Prednisolone/Nystatin/FradiomycinMetronidazole-Prednisolone-Nystatin-Neomycin甲硝唑•泼尼松龙•制霉菌素•新霉素Metronidazole,Prednisolone,Nystatin and Neomycin +[7] 
ClassificationSmall molecules > SteroidsSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsDNA synthesis inhibitorsGlucocorticoid receptor agonists +[4] 
TargetsErgosterolGlucocorticoid receptorBacterial penicillin-binding protein
Therapy Area/IndicationsVaginosis, Bacterial
Global Approved IndicationsVaginosis, Bacterial
Approved Indications in ChinaN/A
Original Approved Country/TerritoryFrance
Original Approved Date2005/09/01
Country/TerritoryFrance
CombinationsYes PrednisoloneMetronidazoleFradiomycin sulfate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesRecordati
China Registration ClassN/A

Develop Information

Active CompaniesRecordati Spa
Inactive CompaniesN/A
Active IndicationsVaginosis, Bacterial
Inactive IndicationsN/A

Other Information

ATC CodeJ01
Related LinksN/A